Structures of 4-{3-(X-phenyl)perhydro-1,3-oxazolo[3,4-a]pyridin-1-yl}-2,8- bis(trifluoromethyl)quinolines (X = H, 2-O2N, 3-O2N and 4-O2N), derived from mefloquine

Zeitschrift fur Kristallographie

Volumn 226, Issue 10, 2011, Pages 793-803

  Gonçlves, Raoni S B ^a,b   Kaiser, Carlos R ^b   De Souza, Marcus V N ^a   Wardell, James L ^a   Wardell, Solange M S V ^c   Howie, R Alan ^d  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c CHEMSOL   (United Kingdom)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Hydrogen bonding; Intermolecular interactions; Mefloquine derivatives; Single crystal structure analysis; X ray diffraction

Indexed keywords

EID: 80053897409     PISSN: 00442968     EISSN: None     Source Type: Journal    
DOI: 10.1524/zkri.2011.1426     Document Type: Article

References (49)

1. Maguire, J. D.; Krisin, Marwoto, H.; Richie, T. L.; Fryauff, D. J.; Baird, J. K.: Mefloquine is highly efficacious against chloroquine-resistant Plasmodium vivax malaria and Plasmodium falciparum malaria in Papua, Indonesia. Clin. Infect. Dis. 42 (2006) 1067-72.
2. Kunin, C. M.; Ellis, W. Y.: Antimicrobial Activities of Mefloquine and a Series of Related Compounds. Antimicrob. Agents Chemother. 44 (2000) 848-852. (Pubitemid 30165259)
3. Bermudez, L. E.; Kolonoski, P.; Wu, M.; Aralar, P. A.; Inderlied, C. B.; Young, L. S.: Mefloquine is active in vitro and in vivo against Mycobacterium avium complex. Antimicrob. Agents Chemother. 43 (1999) 1870-1874. (Pubitemid 29395178)
4. Danelishvili, L.; Wu, M.; Young, L. S.; Bermudez, L. E.: Genomic approach to identifying the putative target of and mechanisms of resistance to mefloquine in mycobacteria. Antimicrob. Agents Chemother. 49 (2005) 3707-3714. (Pubitemid 41233022)
5. Jayaprakash, S.; Iso, Y.; Wan, B.; Franzblau, S. G.; Kozikowski, A. P.: Design, Synthesis, and SAR Studies of Mefloquine-Based Ligands as Potential Antituberculosis Agents. ChemMedChem 1 (2006) 593-597. (Pubitemid 44105784)
6. Bermudez, L. E.; Kolonoski, P.; Seitz, L. E.; Petrofsky, M.; Reynolds, R.; Wu, M.; Young, L. S.: SRI-286, a Thiosemicarbazole, in Combination with Mefloquine and Moxifloxacin for Treatment of Murine Mycobacterium avium Complex Disease. Antimicrob. Agents Chemother. 48 (2004) 3556-3558. (Pubitemid 39129359)
7. Roesner, M.; Brossi, A.; Silverton, J. V.: Structure, Chemistry, and Antimalarial Properties of Mefloquineaziridine. Heterocycles 15 (1981) 925-933.
8. Croft, A. M.; Herxheimer, A.: Adverse effects of the antimalaria drug, mefloquine: due to primary liver damage with secondary thyroid involvement? BMC Public Health. 2 : 6. Published online 2002 March 25. doi:10.1186/1471-2458-2-6.
9. Lima, P. C.; Avery, M. A.; Tekwani, B. L.; Alves, H. de M.; Barreiro, E. J.; Fraga, C. A. M.: Synthesis and biological evaluation of new imidazo[1,2-a]pyridine derivatives designed as mefloquine analogues. Il Farmaco 57 (2002) 825-832. (Pubitemid 35440978)
10. Biot, C.; Delhaes, L.; Maciejewski, L. A.; Mortuaire, M.; Camus, D.; Dive, D.; Brocard, J. S.: Synthetic ferrocenic mefloquine and quinine analogues as potential antimalarial agents. Eur. J. Med. Chem. 35 (2002) 707-714. (Pubitemid 30490277)
11. Gonçalves, R. S. B.; Kaiser, C. R.; Lourenço, M. C. S.; de Souza, M. V. N.; Wardell, J. L.; Wardell, S. M. S. V.; da Silva, A. D.: Synthesis and antitubercular activity of new mefloquine-oxazolidine derivatives. Eur. J. Med. Chem. 45 (2010) 6095-6100.
12. Skórska, A.; Irwinški, J.; Oleksyn, B. J.: Conformation stability and organization of mefloquine molecules in different environments. Bioorg. Med. Chem. Lett. 16 (2006) 850-853. (Pubitemid 43059836)
13. Karle, J. M.; Karle, I. L.: Crystal structure of (-)-mefloquine hydrochloride reveals consistency of configuration with biological activity. Antimicrob. Agents Chemother. 46 (2002) 1529-1534; (Pubitemid 34415338)
14. Karle, J. M.; Karle, I. L.: Structure of the antimalarial (±)-mefloquine hydrochloride. Acta Crystallogr. C47 (1991) 2391-2393;
15. italiga, A.; Prado, L. D.; Seisceiras, R.; Wardell, J. L.; Wardell, S. M. S. V.: X-Ray crystal structures at 120 K of (±)-mefloquinium hydrochloride.hemi-methanol solvate, (±)-mefloquinium hydrochloride.hemihydrate and (±)-mefloquinium hydrochloride. monohydrate. Further characterization using X-ray powder patterns, DSC and infrared data. Int. J. Pharm. 398 (2010) 50-60.
16. Wardell, J. L; de Souza, M. V. N.; Wardell, S. M. S. V.; Lourenço, M. C. S.: Mefloquine derivatives: crystal structures and anti-tubercular activities of diphenyl-[((R*,S*)-2,8-bis(trifluoromethyl) quinolin-4-yl)-piperidin-2-yl-methanolato-O,N]boron and (±)-erythro- mefloquinium tetraphenylborate solvates. J. Mol. Struct. 990 (2011) 67-74.
17. Wardell, S. M. S. V.; Wardell, J. L.; Skakle, J. M. S.; Tiekink, E. R. T.: Structural study of mefloquinium salts with three isomeric n-nitrobenzoates (n = 2, 3, and 4). Z. Kristallogr. 226 (2011) 68-77.
18. Karle, J. M.; Karle, I. L.: Crystal structure and molecular structure of mefloquine methylsulfonate monohydrate - implications for a malaria receptor. Antimicrob. Agents Chemother. 35 (1991) 2238-2245.
19. Wardell, J. L.; Wardell, S. M. S. V.; Tiekink, E. R. T.; de Lima, G. M.: Bis(2-{[2,8-bis(trifloromethyl)quinolin-4-yl](hydroxymethyl)} piperidin-1-ium) tetrachloridodiphenylstannate (IV). Acta Crystallogr. E66 (2010) m336-m337.
20. Obaleye, J. A.; Caira, M. R.; Tella, A. C.: Synthesis, characterization and crystal structures of the tetrachlorocuprate and tetrabromocadmate salts of the antimalarial mefloquine. Struct. Chem. 20 (2009) 859-868.
21. Hubel, R.; Polborn, K.; Knizek, J.; Noth, H.; Beck, W.: Metal complexes of biologically important ligands. CXXVI. Palladium(II) and platinum(II) complexes with the antimalarial drug mefloquine as ligand. Z. Anorg. Chem. Allg. Chem. 626 (2000) 1701-1708.
22. Moloney, G. P.; Craik, D. J.; Iskander, M. N.; Nero, T. L.: Synthesis, NMR studies and conformational analysis of oxazolidine derivatives of the b-adrenoreceptor antagonists metoprolol, atenolol and timolol. J. Chem. Soc. Perkin Trans. 2, (1998) 199-206. (Pubitemid 128434877)
23. Andes, D.; van Ogtrop, M. L.; Peng, J.; Criag, W. A.: In Vivo Pharmacodynamics of a New Oxazolidinone (Linezolid). Antimicrob. Agents Chemother. 46 (2002) 3484-3489. (Pubitemid 35192915)
24. Kumar, V.; Mudgal, M. M.; Rani, N.; Jha, A.; Jaggi, M.; Singh, A. T.; Sanna, V. K.; Singh, P.; Sharma, P. K.; Irchhaiya, R.; Burman, A. C.: Synthesis of functionalized amino acid derivatives as new pharmacophores for designing anticancer agents. J. Enzyme Inhib. Med. Chem. 24 (2009) 763-770.
25. Cremer, D.; Pople, J. A.: General definition of ring puckering coordinates. J. Am. Chem. Soc. 97 (1975) 1354-1358.
26. Spek, A. L.: Single-crystal structure validation with the program PLATON. J. Appl. Crystallogr. 36 (2003) 7-13.
27. Nishio, M.: CH/π hydrogen bonds in crystals. CrystEngComm. 6 (2004) 130-158;
28. Merz, K.; Vasylyeva, V.: Development and boundaries in the field of supramolecular synthons. CrystEngComm. 12 (2010) 3989-4002;
29. Mingos, D. M. P.: (Ed.), Supramolecular Assembly via Hydrogen Bonds I and II (Structure and Bonding, vols. 108 and 111), Springer, Berlin/Heidelberg, 2004;
30. Desiraju, G. R.; Steiner, T.: The Weak Hydrogen Bond, Oxford University Press, New York, 1999.
31. Reichenbacher, K.; Suss, H. I.; Hulliger, J.: Fluorine in crystal engineeing - 'the little atom that could', Chem. Soc. Revs. 34 (2005) 22-30; (Pubitemid 40311180)
32. Brammer, L.; Brutton, E. A.; Sherwood, P.: Understanding the behavior of halogens as hydrogen bond acceptors. Cryst. Growth Des. 4 (2001) 277-290; (Pubitemid 33680419)
33. Schwarzer, A.; Weber, E.: Influence of fluorine substitution on the packing of N-phenylmaleimides and corresponding phthalimides. Cryst. Growth Des. 8 (2008) 2862-2874;
34. Prasanna, M. D.; Row, T. N. G.: C-halogen ⋯ π interactions and their influence on molecular conformation and crystal packing: a data base study. Cryst Eng. 3 (2000) 135-154;
35. Chopra, D.; Row, T. N. G.: Role of Fluorine in crystal engineeering. CrystEngComm. 13 (2011) 2175-2186;
36. Bereger, R.; Resnati, G.; Metrangolo, P.; Weber, E.; Hulliger. J.: Organic fluorine compounds: great opportunity for enhanced materials properties. Chem. Soc. Rev. 40 (2011) 3496-3508;
37. O'Hagan, D.: Understanding organofluorine chemistry. An introduction to the C-F bond. Chem. Soc. Rev. 37 (2008) 308-317;
38. Merz, K.; Vasylyeva, V.: Development and boundaries in the field of supramolecular synthons. CrystChemComm. 12 (2010) 3989-4002.
39. Emmerling, F.; Orgzall, I.; Dietzel, B.; Schulz, B. W.; Reck, G.; Schulz, B.: Structural studies on trifluoromethyl substituted 2,5-diphenyl-1,3,4- oxadiazoles. J. Mol. Struct. 832 (2007) 124-131. (Pubitemid 46367049)
40. Sikorski, A.; Krzyminski, K.; Niziolek, A.; Blazejowski, J.: 9-(2,6-difluorophenoxycarbonyl)-10-methylacridinium trifluoromethanesulfonate and its precursor 2,6-difluorophenylacridine-9-carboxylate: C-H⋯ O, C-F ⋯ π, S-O⋯ π and π ⋯ π stacking interactions. Acta Crystallogr. C61 (2005) o690-o694.
41. Wu, J.; Chen, L.-S.; Liu, Q.-K.; Guo, D.-S.: [8-(2,2,2-trifluoroethoxy) quinolinium perchlorate][[8-(2,2,2-trifluoroethoxy)quinoline], (1/1). Acta Crystallogr. E67 (2011) o1131-o1132.
42. Huang, L.; Massa, L.; Karle, J.: Calculated interactions of a nitro group with aromatic rings of crystalline picryl bromide. Proc. Natl. Acad. Sci. 105 (2008) 3720-13723.
43. Bernstein, J.; Davis, R. E.; Shimoni, L.; Chang, N. L.: Patterns in hydrogen bonding: Functionality and graph set analysis in crystals. Angew. Chem. Int. Ed. Engl. 34 (1995) 1555-1573.
44. Hooft, R. W. W.: COLLECT, data collection software. Nonius BV, Delft, The Netherlands, (1998).
45. Otwinowski, Z.; Minor, W.: Processing of X-ray diffraction data collected in oscillation mode. Methods in Enzymology, Vol. 276, Macromolecular Crystallography, Part A, edited by Carter Jr, C. W.; Sweet, R. M. pp. 307-326. New York: Academic Press, (1997). (Pubitemid 27085611)
46. Sheldrick, G. M.: SADABS Version 2007/2, Bruker AXS Inc., Madison, Wisconsin, USA (2007).
47. Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112-122.
48. Farrugia, L. J.: ORTEP-3 for Windows - a version of ORTEPIII with a Graphical User Interface (GUI). J. Appl. Crystallogr. 30 (1997) 565. (Pubitemid 127791756)
49. Mercury 2.4. The Cambridge Crystallographic Data Centre, UK.